- Home
- JANX vs GOOS Comparison
JANX vs GOOS Comparison
Compare JANX & GOOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- GOOS
- Stock Information
- Founded
- JANX 2017
- GOOS 1957
- Country
- JANX United States
- GOOS Canada
- Employees
- JANX N/A
- GOOS N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- GOOS
- Sector
- JANX Health Care
- GOOS
- Exchange
- JANX Nasdaq
- GOOS Nasdaq
- Market Cap
- JANX 1.4B
- GOOS 1.1B
- IPO Year
- JANX 2021
- GOOS 2017
- Fundamental
- Price
- JANX $23.98
- GOOS $13.40
- Analyst Decision
- JANX Strong Buy
- GOOS Sell
- Analyst Count
- JANX 9
- GOOS 4
- Target Price
- JANX $85.00
- GOOS $11.00
- AVG Volume (30 Days)
- JANX 745.4K
- GOOS 1.7M
- Earning Date
- JANX 08-07-2025
- GOOS 07-31-2025
- Dividend Yield
- JANX N/A
- GOOS N/A
- EPS Growth
- JANX N/A
- GOOS N/A
- EPS
- JANX N/A
- GOOS 0.35
- Revenue
- JANX $439,000.00
- GOOS $1,001,779,346.00
- Revenue This Year
- JANX N/A
- GOOS $8.65
- Revenue Next Year
- JANX $591.60
- GOOS $5.73
- P/E Ratio
- JANX N/A
- GOOS $37.84
- Revenue Growth
- JANX N/A
- GOOS 2.32
- 52 Week Low
- JANX $21.97
- GOOS $6.73
- 52 Week High
- JANX $71.71
- GOOS $15.43
- Technical
- Relative Strength Index (RSI)
- JANX 49.92
- GOOS 61.20
- Support Level
- JANX $22.41
- GOOS $12.82
- Resistance Level
- JANX $24.00
- GOOS $13.41
- Average True Range (ATR)
- JANX 1.10
- GOOS 0.53
- MACD
- JANX 0.01
- GOOS 0.21
- Stochastic Oscillator
- JANX 42.20
- GOOS 72.66
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About GOOS Canada Goose Holdings Inc. Subordinate Voting Shares
Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale and Direct to Consumer (DTC), Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia, and Europe, the Middle East, and Africa.